• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低能量髋部、脊柱和远端前臂骨折后长达 18 个月的生活质量:ICUROS 的研究结果。

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.

机构信息

Mapi, Stockholm, Sweden.

LIME/MMC, Karolinska Institutet, Stockholm, Sweden.

出版信息

Osteoporos Int. 2018 Mar;29(3):557-566. doi: 10.1007/s00198-017-4317-4. Epub 2017 Dec 11.

DOI:10.1007/s00198-017-4317-4
PMID:29230511
Abstract

UNLABELLED

This study used data from the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) to estimate the quality of life (QoL) impact of fracture. Hip, vertebral, and distal forearm fractures incur substantial QoL losses. Hip and vertebral fracture results in markedly impaired QoL for at least 18 months.

INTRODUCTION

The International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) is a multinational observational study that aims to describe costs and quality of life (QoL) consequences of osteoporotic fractures. To date, 11 countries have participated in the study: Australia, Austria, Estonia, France, Italy, Lithuania, Mexico, Russia, Spain, the UK, and the USA. The objective of this paper is to describe the QoL impact of hip, vertebral, and distal forearm fracture.

METHODS

Data were collected at four time-points for five QoL point estimates: within 2 weeks after fracture (including pre-fracture recall) and at 4, 12, and 18 months after fracture. Quality of life was measured as health state utility values (HSUVs) derived from the EQ-5D-3L. Complete case analysis was conducted as the base case with available case and multiple imputation performed as sensitivity analyses. Multivariate analysis was performed to explore predictors of QoL impact of fracture.

RESULTS

Among 5456 patients enrolled using convenience sampling, 3021 patients were eligible for the base case analysis (1415 hip, 1047 distal forearm, and 559 vertebral fractures). The mean (SD) difference between HSUV before and after fracture for hip, vertebral, and distal forearm fracture was estimated at 0.89 (0.40), 0.67 (0.45), and 0.48 (0.34), respectively (p < 0.001 for all fracture types). Eighteen months after fracture, mean HSUVs were lower than before the fracture in patients with hip fracture (0.66 vs. 0.77 p < 0.001) and vertebral fracture (0.70 vs. 0.83 p < 0.001). Hospitalization and higher recalled pre-fracture QoL were associated with increased QoL impact for all fracture types.

CONCLUSIONS

Hip, vertebral, and distal forearm fractures incur substantial loss in QoL and for patients with hip or vertebral fracture, QoL is markedly impaired for at least 18 months.

摘要

目的

本研究使用国际骨质疏松性骨折成本与效用研究(ICUROS)的数据,估算骨折对生活质量(QoL)的影响。髋部、椎体和远端前臂骨折会导致 QoL 显著下降。髋部和椎体骨折至少 18 个月后会显著降低 QoL。

方法

在骨折后 4、12 和 18 个月进行了 5 次 QoL 点估计的 4 次时间点数据采集。使用 EQ-5D-3L 衍生的健康状态效用值(HSUVs)测量生活质量。采用完全案例分析作为基础分析,进行可用案例和多重插补的敏感性分析。采用多变量分析来探讨骨折对 QoL 影响的预测因素。

结果

在采用便利抽样纳入的 5456 例患者中,3021 例患者符合基础分析的条件(1415 例髋部、1047 例远端前臂和 559 例椎体骨折)。髋部、椎体和远端前臂骨折后 HSUV 与骨折前的平均(SD)差值分别估计为 0.89(0.40)、0.67(0.45)和 0.48(0.34)(所有骨折类型均 p<0.001)。骨折后 18 个月,髋部骨折(0.66 比 0.77,p<0.001)和椎体骨折(0.70 比 0.83,p<0.001)患者的 HSUV 均低于骨折前。住院和更高的骨折前回忆 QoL 与所有骨折类型的 QoL 影响增加相关。

结论

髋部、椎体和远端前臂骨折会导致 QoL 显著下降,且对于髋部或椎体骨折患者,QoL 至少在 18 个月内显著受损。

相似文献

1
Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.低能量髋部、脊柱和远端前臂骨折后长达 18 个月的生活质量:ICUROS 的研究结果。
Osteoporos Int. 2018 Mar;29(3):557-566. doi: 10.1007/s00198-017-4317-4. Epub 2017 Dec 11.
2
The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture.国际骨质疏松性骨折相关成本和效用研究(ICUROS)--骨折后 4 个月内的生活质量。
Osteoporos Int. 2013 Mar;24(3):811-23. doi: 10.1007/s00198-012-2240-2. Epub 2013 Jan 10.
3
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.采用 EQ-5D-3L、EQ-VAS 和时间权衡法评估髋部、椎体和远端前臂脆性骨折后的生活质量:来自 ICUROS 的结果。
Qual Life Res. 2018 Mar;27(3):707-716. doi: 10.1007/s11136-017-1748-5. Epub 2017 Dec 12.
4
Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS).俄罗斯联邦脆性骨折后的生活质量:来自国际与骨质疏松性骨折相关的成本和效用研究(ICUROS)俄罗斯分部的结果。
Arch Osteoporos. 2020 Mar 2;15(1):37. doi: 10.1007/s11657-020-0699-6.
5
Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).髋部骨折后第一年的健康相关生活质量:国际骨质疏松性骨折成本和效用相关研究(MexICUROS)墨西哥部分的结果。
Osteoporos Int. 2018 May;29(5):1147-1154. doi: 10.1007/s00198-018-4389-9. Epub 2018 Feb 20.
6
Health service use pathways associated with recovery of quality of life at 12-months for individual fracture sites: Analyses of the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS).与个体骨折部位在 12 个月时生活质量恢复相关的卫生服务使用途径:国际骨质疏松性骨折相关成本和效用研究(ICUROS)分析。
Bone. 2021 Mar;144:115805. doi: 10.1016/j.bone.2020.115805. Epub 2020 Dec 13.
7
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS study.法国一项 ICUROS 研究显示:髋部、临床椎体、前臂远端或肱骨近端脆性骨折后 18 个月的患者管理成本。
Osteoporos Int. 2022 Mar;33(3):625-635. doi: 10.1007/s00198-021-06189-7. Epub 2021 Oct 12.
8
Health Service Use and Quality of Life Recovery 12 Months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).重大骨质疏松性骨折后 12 个月的卫生服务利用和生活质量恢复:国际骨质疏松性骨折相关成本和效用研究(ICUROS)的潜在类别分析。
J Bone Miner Res. 2021 Feb;36(2):252-261. doi: 10.1002/jbmr.4181. Epub 2020 Oct 14.
9
Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.骨质疏松症临床试验中椎体和非椎体骨折前后的健康状态效用值和患者报告结局。
Osteoporos Int. 2017 Jun;28(6):1893-1901. doi: 10.1007/s00198-017-3966-7. Epub 2017 Mar 6.
10
Sequential change in quality of life for patients with incident clinical fractures: a prospective study.连续变化的生活质量的患者与临床骨折的发生率:一项前瞻性研究。
Osteoporos Int. 2009 May;20(5):695-702. doi: 10.1007/s00198-008-0761-5. Epub 2008 Oct 3.

引用本文的文献

1
Can Multi-Vertebral CT-Based Finite Element Models Accurately Predict Strains? An In Vitro Validation Study.基于多椎体CT的有限元模型能否准确预测应变?一项体外验证研究。
Int J Numer Method Biomed Eng. 2025 Aug;41(8):e70085. doi: 10.1002/cnm.70085.
2
A comprehensive update on the cost-effectiveness of 10-year denosumab vs alendronate in postmenopausal women with osteoporosis in the United States.美国绝经后骨质疏松症女性中,10年地诺单抗与阿仑膦酸钠成本效益的全面更新。
Arch Osteoporos. 2025 Jun 30;20(1):85. doi: 10.1007/s11657-025-01564-x.
3
Longitudinal patient outcomes over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fracture in the United States: results from the ICUROS US study.

本文引用的文献

1
Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium.使用残疾调整生命年来衡量髋部骨折的负担:CHANCE 联盟中前瞻性队列的汇总分析。
Lancet Public Health. 2017 May;2(5):e239-e246. doi: 10.1016/S2468-2667(17)30046-4. Epub 2017 Apr 11.
2
Estimating the long-term functional burden of osteoporosis-related fractures.估算与骨质疏松性骨折相关的长期功能负担。
Osteoporos Int. 2017 Oct;28(10):2843-2851. doi: 10.1007/s00198-017-4110-4. Epub 2017 Jun 24.
3
Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality.
美国髋部、临床椎体、前臂远端或肱骨近端骨折后18个月的纵向患者预后:ICUROS美国研究结果
JBMR Plus. 2025 May 30;9(7):ziaf077. doi: 10.1093/jbmrpl/ziaf077. eCollection 2025 Jul.
4
ANTIEPILEPTIC DRUGS AND BONE HEALTH: A COMPREHENSIVE REVIEW AND META-ANALYSIS.抗癫痫药物与骨骼健康:一项全面综述与荟萃分析
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):356-372. doi: 10.4183/aeb.2024.356. Epub 2025 May 23.
5
Bone Health, Fragility Fractures, and the Hand Surgeon.骨骼健康、脆性骨折与手外科医生
J Hand Surg Glob Online. 2025 Mar 12;7(3):100709. doi: 10.1016/j.jhsg.2025.02.002. eCollection 2025 May.
6
Cost‑effectiveness analysis of fracture liaison services in Iran.伊朗骨折联络服务的成本效益分析。
Arch Osteoporos. 2025 Jun 6;20(1):72. doi: 10.1007/s11657-025-01555-y.
7
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study.高分化胃肠胰神经内分泌肿瘤中的脆性骨折:一项多中心回顾性研究的结果
J Neuroendocrinol. 2025 Sep;37(9):e70053. doi: 10.1111/jne.70053. Epub 2025 Jun 1.
8
Cost-effectiveness of opportunistic osteoporosis screening using chest radiographs with deep learning in Germany.在德国使用深度学习胸部X光片进行机会性骨质疏松症筛查的成本效益
Aging Clin Exp Res. 2025 May 13;37(1):149. doi: 10.1007/s40520-025-03048-x.
9
Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico.罗莫佐单抗治疗墨西哥骨折极高风险的重度绝经后骨质疏松症的成本效益分析。
PLoS One. 2025 Feb 7;20(2):e0299673. doi: 10.1371/journal.pone.0299673. eCollection 2025.
10
Exploring the potential cost-effectiveness and societal burden implications of screening for fracture risk in a UK general radiography setting.探索在英国普通放射检查环境中进行骨折风险筛查的潜在成本效益及对社会负担的影响。
BMC Musculoskelet Disord. 2025 Feb 4;26(1):112. doi: 10.1186/s12891-024-08202-6.
全人群非髋非椎体骨折对死亡率的影响。
J Bone Miner Res. 2017 Sep;32(9):1802-1810. doi: 10.1002/jbmr.3118. Epub 2017 May 15.
4
A critical review of the long-term disability outcomes following hip fracture.对髋部骨折后长期残疾结果的批判性综述。
BMC Geriatr. 2016 Sep 2;16(1):158. doi: 10.1186/s12877-016-0332-0.
5
Developing a core outcome set for hip fracture trials.制定髋部骨折试验的核心结局集。
Bone Joint J. 2014 Aug;96-B(8):1016-23. doi: 10.1302/0301-620X.96B8.33766.
6
Epidemiology of distal forearm fractures in Austria between 1989 and 2010.1989年至2010年间奥地利前臂远端骨折的流行病学情况。
Osteoporos Int. 2014 Sep;25(9):2297-306. doi: 10.1007/s00198-014-2766-6. Epub 2014 Jun 17.
7
Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study.2000 - 2010年英国髋部骨折患者的死亡率:一项基于人群的回顾性队列研究。
Bone. 2014 Sep;66:171-7. doi: 10.1016/j.bone.2014.06.011. Epub 2014 Jun 14.
8
The minimum clinically important difference for EQ-5D index: a critical review.EQ-5D指数的最小临床重要差异:一项批判性综述。
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 10.1586/14737167.2014.894462.
9
A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.一项基于效用的骨质疏松相关疾病生活质量的系统评价与荟萃分析。
Osteoporos Int. 2014 Aug;25(8):1987-97. doi: 10.1007/s00198-014-2636-2. Epub 2014 Feb 22.
10
Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).欧盟的骨质疏松症:医疗管理、流行病学和经济负担。这份报告是与国际骨质疏松基金会(IOF)和欧洲制药工业协会联合会(EFPIA)合作编写的。
Arch Osteoporos. 2013;8(1):136. doi: 10.1007/s11657-013-0136-1. Epub 2013 Oct 11.